Dow Down 0.18% Nasdaq Up 0.39%

ARCA biopharma, Inc. (ABIO)

-NasdaqCM
1.37 0.03(2.14%) Sep 2, 3:59PM EDT
Prev Close:1.40
Open:1.40
Bid:1.30 x 1000
Ask:1.50 x 400
1y Target Est:3.75
Beta:2.1
Next Earnings Date:N/A
Day's Range:1.34 - 1.40
52wk Range:1.19 - 2.54
Volume:136,678
Avg Vol (3m):161,681
Market Cap:28.78M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABIODown 2.14%28.78M
AZN94.27B
GSK115.99B
ILIU32.77M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatm... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback